Tag: Treat

  • Chagas disease: providing free paediatric medicine can enhance diagnosis and treatment

    Documentation resulting in the donation of an important antiparasitic medicine for the treatment of Chagas illness to the World Health Organization (WHO) is within the ultimate stage of preparation.

    A 3-year settlement, between the Mundo Sano Foundation1 (Brazil) and WHO, is anticipated to make obtainable 108 000 tablets of the paediatric formulation of benznidazole2 – a first-line medicine towards Chagas illness. Treatment3 with benznidazole within the early levels of an infection can treatment Chagas illness.

    “Making benznidazole freely obtainable for the treatment of newborns till the age of 18 might be a game-changer within the battle towards Chagas illness” mentioned Dr Mwelece Ntuli Malecela, Director, WHO Department of Control of Neglected Tropical
    Diseases. “This is not going to solely save future generations from growing life-threatening and deadly issues however can even increase up diagnosis and treatment.”

    Each yr, an estimated 15 000 youngsters are born from contaminated moms. A freely obtainable paediatric presentation of benznidazole with correct dosage is essentially anticipated to contribute to deal with congenital infections.

    “Treating newborns and youngsters was the lacking hyperlink, as we transfer decisively to advocate for the mixing of diagnosis of an infection amongst pregnant ladies and women of child-bearing age into different surveillance programmes, together with HIV and syphilis” mentioned Dr Pedro Albajar Vinas, Medical Officer with WHO’s Department of Control of Neglected Tropical Diseases.  “Diagnosing and treating ladies of this age group earlier than being pregnant can increase successfully stop congenital transmission.” 

    The settlement

    The donation by Mundo Sano Foundation at some point of the settlement includes benznidazole:

    • 105,000 tablets of 100mg
    • 3,000 tablets of 12.5mg

    Furthermore, the Foundation might donate funds of as much as US$100 000 at some point of the settlement to help actions related to distribution of medicines and conferences. The Foundation additionally makes provision for an extension of this settlement past
    the required length of three years.

    The illness

    Chagas illness, often known as American trypanosomiasis, is a doubtlessly life-threatening sickness brought on by the protozoan parasite Trypanosoma cruzi (T. cruzi).

    Although appreciable progress has been achieved, significantly in decreasing vector transmission and screening of blood and organ provide, reaching and diagnosing individuals most affected has been a problem.

    Currently, under-diagnosis of Chagas illness instances is as excessive as 90% and under-diagnosis of congenital transmission is believed to be even greater.

    Globally, an estimated 6-7 million individuals are contaminated with T. cruzi.

    The illness is discovered primarily in endemic areas of 21 continental Latin American international locations4. But motion of individuals to city areas and to different continents has expanded its transmission by means of non vectorial routes, akin to blood transfusion, congenital
    transmission, organ transplants and oral meals contamination.

    Considering the illness as a rising public well being drawback in lots of international locations, the World Health Assembly – WHO’s decision-making physique – determined in May 2019 to commemorate World Chagas Disease Day on 14 April.

    The inaugural celebration occurs this yr.


    1 Mundo Sano is a nonprofit worldwide basis working with the general public and personal sectors, academia, and different worldwide organizations to supply options to the affected communities and generate scientific information. In 2012, it led a public-private consortium in 2012 to provide benznidazole in Argentina.

    2 In 2017, the United States Food and Drug Administration (FDA) accepted benznidazole for the treatment of kids aged 2–12, making it the primary treatment accepted within the United States for Chagas illness.

    3 Nifurtimox can be 100% efficient in curing Chagas illness if given quickly after onset of an infection, together with instances of congenital an infection. It is donated by Bayer who pledged greater than 7.5 million tablets for the interval 2012-2021.

    4 Argentina, Belize, Bolivia (Plurinational State of), Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay, and Venezuela
    (Bolivarian Republic of).

    Chagas disease: providing free paediatric medicine can enhance diagnosis and treatment
    Read More
    https://www.who.int/news-room/detail/02-04-2020-chagas-disease-providing-free-paediatric-medicine-can-enhance-diagnosis-and-treatment

    Views: 0

  • Remdesivir to be used in treatment of Covid-19: Health DG

    Remdesivir to be used in treatment of Covid-19: Health DG

    Remdesivir to be used in treatment of Covid-19: Health DG 1

    PUTRAJAYA: A brand new antiviral drug, Remdesivir, will be launched to deal with Covid-19 sufferers in the nation, stated Health Director-General Datuk Dr Noor Hisham Abdullah (pix).

    He stated the Ministry of Health (MOH) has acquired a number of purposes to convey in the drugs.

    “There have been purposes to convey in the Remdesivir drug and now we have accepted one or two purposes. Insya Allah, we’ll introduce this new drug to deal with Covid-19 sufferers,“ he stated at a day by day media convention on Covid-19 right here at present.

    Last March 28, Dr Noor Hisham was reported to have stated that the prevailing medication Clorokuin, Hydroxychloroquine and mixture of Lopinavir / Ritonavir which are used to deal with different ailments might be used in the treatment of Covid-19.

    Asked if the quantity of Covid-19 assessments carried out to date was sufficient, he stated MOH had met the World Health Organisation’s (WHO) benchmark.

    He stated primarily based on the share of 7.2% Covid-19 constructive circumstances from all samples taken, it’s under the 10% set by the World Health Organisation (WHO), therefore exhibiting that the nation has been performing sufficient assessments.

    “We have taken 43,462 samples and the (quantity of) constructive circumstances are 3,116, which means the speed of our constructive circumstances is 7.2%,,“ he added.

    Prior to this, medical specialists claimed that Malaysia remains to be behind in conducting the assessments for Covid-19, regardless of the rise in constructive circumstances two weeks in the past.

    Meanwhile, Noor Hisham stated the Covid-19 mortality fee in Malaysia, which is at 1.6 %, is taken into account nonetheless low, in contrast with the worldwide loss of life fee of round 4.5%.

    On the scarcity of private protecting tools (PPE), he stated, the issue has been resolved, however the concern now could be to ship the provides to hospitals and clinics concerned in the treatment of Covid-19.

    However, he stated, efforts had been being made to resolve the matter.

    “We hope inside this week the difficulty of distribution will be settled, now we have greater than 50,000 donated masks and PPE, in addition to half 1,000,000 masks from China for instance.

    “There is rather a lot of donations coming in and the difficulty now could be we try our greatest to handle the logistic to ship to Sabah and Sarawak for instance,“ he added. — Bernama

    Remdesivir to be used in treatment of Covid-19: Health DG
    Read More
    https://www.thesundaily.my/local/remdesivir-to-be-used-in-treatment-of-covid-19-health-dg-FD2207124

    Views: 0

  • Medical Product Alert N°3/2020

    This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat or cure COVID-19. 

    The Coronavirus disease (COVID-19) pandemic (caused by the virus SARS-CoV-2) has increased demand for medicines, vaccines, diagnostics and reagents, all related to COVID-19, creating an opportunity for ill-intended persons to distribute falsified medical products 

    Due diligence is required from all actors in the procurement, use and administration of medical products, in particular those affected by the current crisis of, or related to, COVID-19. 

    1. FALSIFIED IN VITRO DIAGNOSTICS AND LABORATORY REAGENTS 

    WHO has received multiple reports regarding falsified in vitro diagnostics (IVDs) and laboratory reagents for the detection of SARS-CoV-2. Please refer to WHO’s Emergency Use Listing for a list of diagnostics approved for clinical use by WHO. To date, eight countries (Australia, Brazil, Canada, PR China, Russian Federation, Singapore, Republic of Korea, United States of America) have listed IVDs for COVID-19 diagnosis based on expedited regulatory assessments. Please note that, in the European Union, regulatory compliance for SARS-CoV-2 diagnostics are self-declared by the manufacturer.  

    To assist Member States and stakeholders, WHO has published the links to these emergency lists, together with contact details. These links provide information on IVDs authorized for use in the jurisdictions of the International Medical Device Regulators Forum, as well as policies and guidance. WHO will provide updated versions as new information becomes available.

    End-users are encouraged to check the labelling against the information posted by regulatory authorities upon listing to ensure they are in possession of the genuine product. This information might include product name, product code, expiry date, instructions for use and manufacturer details. 

    Unregulated websites supplying medicines and/or vaccines, particularly those concealing their physical address or landline telephone number, are frequently the source of unlicensed, substandard and falsified medical products. WHO has been made aware of various unregistered websites claiming that products on sale can treat or prevent COVID-19. Such products are likely to be falsified medicines. In addition, some websites may appear to provide easy access to legitimate medicines that are otherwise not readily available. End-buyers and consumers should be especially wary of such online scams and exert due diligence when purchasing any medical product, whether online or not.

     2. FALSIFIED MEDICINES AND VACCINES

    At this stage, WHO does not recommend any medicines to treat or cure COVID-19. However, the SOLIDARITY trial, led by WHO, is reviewing potential treatments for COVID-19. 

    WHO requests increased vigilance from national health authorities, healthcare professionals, members of the public and supply chain stakeholders worldwide to prevent the distribution of these falsified medical products. Increased vigilance should focus on hospitals, clinics, health centres, clinical laboratories, wholesalers, distributors, pharmacies and any other suppliers of medical products. All medical products must be obtained from authentic and reliable sources. Their authenticity and condition of the product should be carefully checked. Consumers are advised to seek advice from a healthcare professional in case of doubt. 

    National health authorities are requested to immediately notify WHO if these falsified products are discovered in their country. If you have any information concerning the manufacture, distribution, or supply of these products, please contact rapidalert@who.int

    WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products
    For further information, please visit our website: https://www.who.int/medicines/regulation/ssffc/en/ 

    Read More
    https://www.who.int/news-room/detail/31-03-2020-medical-product-alert-n-3-2020

    Views: 0

  • Legal Issues Arising From Management Of Covid-19 Patients By Ahmed Adetola-Kazeem

    Legal Issues Arising From Management Of Covid-19 Patients By Ahmed Adetola-Kazeem

    Legal Issues Arising From Management Of Covid-19 Patients By Ahmed Adetola-Kazeem 2

    Legal Issues Arising From Management Of Covid-19 Patients By Ahmed Adetola-Kazeem 3


    A lot of legal issues are bound to arise as an aftermath of the outbreak of Coronavirus otherwise referred to as COVID-19.  There is therefore a need to shed light on some of the issues that may arise and how to navigate them. This article will x-ray the rights of patients, the rights of health workers and the basic minimum obligations of the government.

    The Code of Medical Ethics in Nigeria 2008 lists acts that constitute professional negligence. Rule 29.4 of the Code outlines some of these acts as follows:-

    a)      Failure to attend promptly to a patient requiring urgent attention when the practitioner was in a position to do so;

    b)     Manifesting incompetence in the assessment of a patient;

    c)      Making an incorrect diagnosis particularly when the clinical features were so glaring that no reasonable skillful practitioner could have failed to notice them; 

    d)     Failure to advise, or proffering wrong advice to  a patient on the risk involved in a particular operation or course of treatment, especially if such an operation or course of treatment is likely to result in serious side effects like deformity or loss of organ, or function;

    e)      Failure to obtain the informed consent of the patient before proceeding on any surgical procedure or course of treatment when such consent was necessary; 

    f)       Making a mistake in treatment e.g. amputation of the wrong limb, carelessness that results in the termination of a pregnancy, prescribing the wrong drug, or dosage in error for a correctly diagnosed ailment, etc;

    g)     Failure to refer, or transfer a patient in good time, when such a referral or transfer was necessary;

    h)     Failure to do anything that ought reasonably to have been done under any circumstance for the good of the patient;

    i)       Failure to see a patient as often as his medical condition warrants or to make appropriate comments in the case notes of the practitioner’s observations and prescribed treatment during such visits. It also includes failure to communicate with the patient or with his relatives as may be necessary with regards to any developments, progress or prognosis in the patient’s condition.

     

    Rule 11.2 of the 2008 Code of Medical Ethics in Nigeria provides that, “A physician shall preserve absolute confidentiality on all he knows about his patient even after the patient has died.”

                 Rule 44 of the Code of Medical Ethics has extensive provisions on Confidentiality and when disclosure of information can be made. The Rule provides in part that:

    “Disclosure of information on the patient by the doctor can only be made following an informed consent of the patient in writing. It is clear that the ethic covers even such information as induced abortion, venereal disease, attempted suicide, concealed birth and drug dependence but would exclude situations in which a discretionary breach of confidentiality is necessary to protect the patient or the community from danger and this must be made clear to the patient at the time of the confidential disclosure. Where statutory notification of disease is involved, the consent of the patient is not required.”            

                Confidentiality: To Disclose Identity Of Covid-19 Patients Or Not To Disclose?

    COVID-19 is an infectious disease caused by a newly discovered coronavirus. Most people infected with the COVID-19 will experience mild to moderate respiratory illness and recover without requiring special treatment.  Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.[1]

    The Federal Ministry of Health confirmed the first case of COVID-19 in Nigeria on the 27th of February 2020. It is the case of an Italian citizen who works in Nigeria and returned from Milan, Italy to Lagos, Nigeria on the 25th of February 2020. In reaction to the report, the social was divided between those who want the name of the Italian disclosed and those that preferred it remains confidential. The outcry was even more when the Chief of Staff to the President tested positive according to reports from various media houses[2], but the Minister of Health decided to keep mute on the identity of the President’s aide who contacted the virus, citing confidentiality.

    It will ordinarily be wrong to disclose the medical status of someone infected with COVID-19, for instancethe case of the Italian who was the index case. However in view of the proviso to Rule 44 of the Code of Medical Ethics 2008 which provides that a discretionary breach of confidentiality is necessary in order to protect the community from danger, I am of the view that the test results of popular figures who hold strategic offices like the Chief of Staff to the President or a Governor must be disclosed to guaranty public safety. This is necessary in view of the countless number of people from all works of life they come in contact with on a daily basis.  It will be correct to have made their status public in the overriding interest of the public, since it will enable those who have come in contact with them isolate, just like we have seen in the cases of the British Prime Minister, the Bauchi State Govenor, Prince Charles, the First Lady of Canada and many more. We must commend those who announced their status in public themselves-it is the best thing to do in the interest of humanity

    The World Health Organization (WHO) provides additional guidelines for the management of coronavirus patients specifically.[3]

    Health workers should:

    •follow established occupational safety and health procedures, avoid exposing others to health and safety risks and participate in employer-provided occupational safety and health training; 

    •use provided protocols to assess, triage and treat patients; 

    •treat patients with respect, compassion and dignity; 

    •maintain patient confidentiality; 

    •swiftly follow established public health reporting procedures of suspect and confirmed cases; 

    •provide or reinforce accurate infection prevention and control and public health information, including to concerned people who have neither symptoms nor risk;

    •put on, use, take off and dispose of personal protective equipment properly;

    •self-monitor for signs of illness and self-isolate or report illness to managers, if it occurs; 

    •advise management if they are experiencing signs of undue stress or mental health challenges that require support interventions; and 

    •report  to  their  immediate  supervisor  any  situation  which  they  have  reasonable  justification  to  believe presents an imminent and serious danger to life or health.

     

    Doctors and health workers in Nigeria must endeavor to digest the guidelines in the Code of Medical Ethics as well as the WHO Guidelines for management of Coronavirus victims and ensure they work strictly by their provisions. A breach of these duties have dire consequences. 

    Options Available To Covid-19 Patients Who Are Victims Of Medical Negligence

    A Coronavirus patient who has suffered medical negligence has a number of options:

    1. He could file a complaint with the regulatory body (e.g. the Medical and Dental Council of Nigeria, in the cases involving a Doctor). The Doctor will in the first instance be investigated by the Medical and Dental Practitioners Investigation Panel, after which he will be tried by the Medical and Dental Practitioners Disciplinary Tribunal. If found culpable,  the Doctor may be warned, suspended from practicing for a period not exceeding 6 months or in very serious cases, have his name can be removed from the Register of Medical Practitioners. The Medical and Dental Practitioners’ Disciplinary Tribunal does not award monetary damages.

    2. A suit can be filed against the Medical Doctor, the Hospital, Agency or Government in the High Court for Medical Negligence and monetary damages will be awarded if the Defendant(s) are found culpable.

          3.  If there is an element of Crime, a report could be made to the Police who would conduct Criminal Investigation and where the investigation reveals gross negligence, recklessness or wanton disregard for life of the victim, the police can prosecute or forward the case file to the office of the Attorney General of the State for possible prosecution in deserving cases.  

    A Need To Do More For Doctors And Other Professionals In The Health Sector

    Health workers are at the front line of any outbreak response and as such are exposed to hazards that put them at risk of infection with an outbreak pathogen (in this case COVID-19). Hazards include pathogen exposure, long working  hours,  psychological  distress,  fatigue,  occupational  burnout,  stigma,  and  physical  and  psychological violence. 

    During the outbreak of Ebola more than 500 health care workers died in Guinea, Liberia and Sierra-Leone alone. We also lost some of our finest doctors and health workers to the disease in Nigeria, the most prominent being Dr. Stella Adadevoh, who is credited with having curbed a wider spread of the Ebola virus in Nigeria by placing the index patient, Patrick Sawyer, in quarantine despite pressures from the Liberian  government. As we speak, The coronavirus is waging a war of attrition against health care workers throughout the world, but nowhere is it winning more battles at the moment than in Italy and in Spain, where protective equipment and tests have been in severely short supply for weeks. In Spain 13.6% (6500) of those affected with the coronavirus are health workers and in Italy 10% (7400) of those affected with the virus are health workers. [4] In New York dozens of health workers have been affected with the virus, while hundreds are in quarantine.[5] According to reports filtering in as the time of concluding this article, three health workers have been infected with COVID-19 in Abuja, Nigeria.[6]

    Human Rights Watch research into health system collapse in Hungary and Venezuela suggests the nations’ mismanaged, underfunded, and understaffed public healthcare system is poorly equipped to handle a COVID-19 outbreak. Patients and medical experts described a lack of basic hygiene protocol, lack of isolation rooms, and a shortage of health professionals, doctors and nurses, and medical supplies in general.

    The situation is not too different in Nigeria at the moment and except something drastic is done we might be witnessing a devastating effect of the pandemic. Nigeria’s, public health capacity has been diminished by large scale public sector corruption. Medical personnel lack surgical masks and local supplies have been diverted and shipped to other markets partly due to corruption. Many states are ill-prepared to combat the impeding surge in patients. A senior health worker with a government hospital in Abuja, in an interview with Sahara Reporters, lamented the lack of quality Personal Protective Equipment for them, adding that government must invest in the protection of health workers at the frontline of the battle against the virus. He said, “The unfortunate thing is that the government is not providing us with what to work with. It is sad that our PPE are not up to the world standard and can be penetrated by viruses. Some of us (health workers) have to use our personal funds to purchase gloves as we do not trust the ones government supplied. Nigerians should please remember us in their prayers and government should provide us with what we really need to work.” [7]

    There was report that in Bauchi State a Coronavirus patient rejected the isolation centre at the Bauchi Specialist Hospital and went back home while describing it as “too dirty”.[8]  

    It is disappointing to hear that the hazard allowance for doctors and health workers is N5,000 per month in Nigeria. The amount is very paltry compared to the risks and the attendant emotional and psychological stress suffered by the health-care workers (HWCs) particularly during monumental outbreaks like this. Unfortunately, when a patient is mismanaged, these doctors and health workers bear the burden of paying huge compensation and sometimes losing their jobs. More importantly, the brain-drain in the health sector is monumental, almost all my friends who are doctors, work abroad. Unfortunately, there are concerted efforts by the US Government to engage foreign Doctors to further fortify its health work force as COVID-19 ravages. Many young Nigerian doctors are already considering the offers because the Nigerian government has paid little attention to their welfare and the welfare of the general health workforce. To stop the exodus of our doctors, who are already in short supply, the government must act fast by improving their welfare packages in line with acceptable international standards.

    The psychological needs of doctors and health workers are also often ignored. Unsafe working conditions contribute to health worker attrition in many countries due to work-related illness and injury and the resulting fear of health workers of occupational infection, including from HIV and Tuberculosis. The 2006 World Health Report – Working Together for Health reported on a severe health workforce crisis in fifty-seven countries, most of them in Africa and Asia. [9]

    Protecting the occupational health of health workers is critical to having an adequate workforce of trained and healthy health personnel. Governments at the Federal and State levels are urged to do more by complying fully with the World Health Organization’s guidelines regarding the Rights of Health Workers while combating COVID-19. Some of the rights are:

    ·         assume overall responsibility to ensure that all necessary preventive and protective measures are taken to minimize occupational safety and health risks;

    ·         provide information, instruction and training on occupational safety and health, including; Refresher training on infection prevention and control(IPC); and Use, putting on, taking off and disposal of personal protective equipment(PPE);

    ·         provide adequate IPC and PPE supplies (masks, gloves, goggles, gowns, hand sanitizer, soap and water, cleaning supplies) in sufficient quantity to healthcare or other staff caring for suspected or confirmed COVID-19 patients, such that workers do not incur expenses for occupational safety and health requirements;

    ·         not be required to return to a work situation where there is continuing orserious danger to life or health, until the employer has taken any necessary remedial action;

    ·         allow workers to exercise the right to remove themselves from a work situation that they have reasonable justification to believe presents an imminent and serious danger to their life or health. When a health worker exercises this right, they shall be protected from any undue consequences; 

    ·         honour the right to compensation, rehabilitation and curative services if infected with COVID-19 following exposure in the workplace. This would be considered occupational exposure and resulting illness would be considered an occupational disease,

    ·         provide access to mental health and counselling resources; and 

    ·         enable co-operation between management and workers and/or their representatives. Etc.

    In conclusion, professional care givers for COVID-19 patients should uphold four basic principles formulated by Beauchamp and Childress in their book ‘Principles of Biomedical Ethics’ in order to protect themselves from liability for negligence. The four basic principles are autonomy, beneficence, non-maleficence and justice.

    Autonomy: People have the right to control what happens to their bodies. This principle simply means that an informed, competent adult patient can refuse or accept treatments, drugs, and surgeries according to their wishes. People have the right to control what happens to their bodies because they are free and rational. And these decisions must be respected by everyone, even if those decisions aren’t in the best interest of the patient.

    Beneficence: All healthcare providers must strive to improve their patient’s health, to do the most good for the patient in every situation. But what is good for one patient may not be good for another, so each situation should be considered individually. And other values that might conflict with beneficence may need to be considered.

    Non-maleficence: “First, do no harm” is the bedrock of medical ethics. In every situation, healthcare providers should avoid causing harm to their patients. You should also be aware of the doctrine of double effect, where a treatment intended for good unintentionally causes harm. This doctrine helps you make difficult decisions about whether actions with double effects can be undertaken.

    Justice: The fourth principle demands that you should try to be as fair as possible when offering treatments to patients and allocating scarce medical resources. You should be able to justify your actions in every situation. For instance, it will amount to a professional misconduct for a Health-care Worker to remove a poor man from the ventilator because a Senator was rushed in. 

    Ahmed Adetola-Kazeem is a partner in Adetola-Kazeem Legal Practice and specializes in Medical and Health Law

    Email: aadetolakazeem@gmail.com;aadetolakazeem@gaklp.com

    [1] https://www.who.int/health-topics/coronavirus#tab=tab_1(Accessed on the 28th of March 2020)

    [2] https://businessday.ng/coronavirus/article/abba-kyari-tests-positive-for-coronavirus-buhari-negative/

    https://www.channelstv.com/2020/03/24/buharis-chief-of-staff-abba-kyari-reportedly-tests-positive-for-coronavirus/ (Accessed on the 28th of March 2020)

    [3] Coronavirus Disease (Covid-19) Outbreak: Rights, Roles and Responsibilities Of Health workers, Including Key Considerations For Occupational Safety And Health”. https://www.who.int/docs/default-source/coronaviruse/who-rights-roles-respon-hw-covid-19.pdf?sfvrsn=bcabd401_0   (Accessed on the 26th of March 2020)

    [4] https://abcnews.go.com/Health/wireStory/collapsing-virus-pummels-medics-spain-italy-69789413 (Accessed on 26th March 2020)

    [5] https://www.washingtonpost.com/health/covid-19-hits-doctors-nurses-emts-threatening-health-system/2020/03/17/f21147e8-67aa-11ea-b313-df458622c2cc_story.html (Accessed on 28th of March 2020)

    [6] http://saharareporters.com/2020/03/28/exclusive-two-nurses-one-doctor-infected-coronavirus-abuja-hospital

    [7] Supra

    [8] https://www.dailytrust.com.ng/coronavirus-patient-rejects-bauchi-isolation-centre-returns-home.html (Accessed on 28th March 2020)

    [9] https://www.who.int/occupational_health/topics/hcworkers/en/(Accessed on 26th March 2020)

     

    Opinion

    AddThis

    : 

    Original Author

    : 

    Ahmed Adetola-Kazeem

    Disable advertisements

    : 
    Legal Issues Arising From Management Of Covid-19 Patients By Ahmed Adetola-Kazeem
    Read More
    http://saharareporters.com/2020/04/01/legal-issues-arising-management-covid-19-patients-ahmed-adetola-kazeem

    Views: 0

  • New York City’s coronavirus outbreak is already overwhelming hospitals

    New York City’s coronavirus outbreak is already overwhelming hospitals

    New York City is the epicentre of the coronavirus outbreak in the US and hospitals are already struggling to treat everyone with covid-19, though the outbreak may not peak for three weeks
    New York City’s coronavirus outbreak is already overwhelming hospitals
    Read More
    https://www.newscientist.com/article/2239247-new-york-citys-coronavirus-outbreak-is-already-overwhelming-hospitals/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home

    Views: 0

  • World TB Day 2020 Newsletter

    World TB Day 2020 Newsletter

    Latest news and updates from WHO

    World TB Day 2020 Newsletter 4

    Dear colleagues and friends,

    World TB Day, this year, comes at a sobering time – as the world grapples with the COVID-19 pandemic. We stand in solidarity with those affected, those at the frontlines of the fight to combat COVID-19, as well as those who continue efforts to support
    those ill with longstanding health problems like TB, HIV and other diseases. However, we cannot forget the millions and their families who battle TB every day and lose their lives to this ancient disease – which remains the world’s top
    infectious killer.

    As eloquently emphasized by WHO Director-General Dr Tedros Adhanom Ghebreyesus in his press briefing on COVID-19 yesterday, “I’d like to remind everyone that although COVID-19 is dominating the world’s attention-there is another respiratory
    disease that is both preventable and treatable, but kills 1.5 million people every year – that disease is tuberculosis”

    “It’s Time”, the focus for World TB Day this year is therefore on urgently accelerating the TB response to save lives and end suffering, even in times of crisis. This will be essential if we are to reach the targets and commitments made
    by Heads of State at the 2018 UN High Level Meeting on TB. 

    We have made important strides against the TB epidemic to date.

    We announced last year, that more people received life-saving treatment for tuberculosis in 2018 than ever before, largely due to improved detection and diagnosis. Globally, 7 million people were diagnosed and treated for TB – up from 6.4 million in 2017
    – enabling the world to meet one of the milestones towards the United Nations political declaration targets on TB and the WHO Director-General Flagship Initiative Find.Treat.All End TB jointly with Stop TB Partnership and the Global Fund. This
    has been a big win for the TB community.

    WHO is working with countries to roll out important guidelines, including a comprehensive package on TB preventive treatment released today, and updated MDR TB guidelines to promote the use of all-oral regimens for patients with drug-resistant TB which
    would be helpful – particularly at this point, when visiting health centers is a challenge. Furthermore, WHO has developed a note to guide and urge countries to ensure continuity of TB services during the COVID-19 pandemic.

    We are strengthening our collaboration with civil society – more information is highlighted in the WHO Civil Society Taskforce Progress Review released today.

    Youth mobilization is being ramped up through the WHO 1+1 Youth Initiative to end TB and the Global Youth Declaration to End TB. Multisectoral accountability is being promoted in countries through our framework and we have finalized a new global strategy
    on TB research and innovation, that will be reviewed by the World Health Assembly.

    Yet, the gains we have made are at risk – if there is any slackening of commitment and action, especially in times of crisis.

    We are at a crossroads and we need to unite forces to take the path of success that will save lives and end suffering.

    I was especially heartened today, to see the TB community coming together like never before. We all took our events to the virtual realm due to COVID-19 lockdowns. The WHO Online Talk Show held this afternoon, had a powerful line up of speakers that included,
    TB survivors and advocates, civil society, high level government representatives, heads of agencies, researchers and partners. As of this evening we have surpassed 10,000 views on YouTube. I also participated in townhalls organized by Stop TB Partnership.
    Our joint efforts have indeed ensured a continuing spotlight on those affected by TB, and clearly shows that no matter what the barrier, we can surpass it if we work together.

    I am proud to stand shoulder-to-shoulder with you all virtually – and recommit to champion End TB efforts till we reach the finish line.

    It’s time to deliver on our promises and ensure no one is left behind.

    It’s time to End TB!

    Dr Tereza Kasaeva
    Director
    Global TB Programme
    World Health Organization


    World TB Day Talk Show

    World TB Day 2020 Newsletter 5

    In the backdrop of the global battle against COVID-19, WHO organized a special online talk show to mark World TB Day 2020. The talk show had a powerful line up of speakers from among TB survivors and advocates, civil society, high-level government representatives,
    heads of agencies, researchers and partners. The video was streamed live on WHO’s Youtube channel crossing over 10,000 views in a few hours. Watch the talk show video


    Spotlight on TB Preventive Treatment

    New WHO recommendations to prevent tuberculosis aim to save millions of lives

    24 March 2020 News release

    Geneva –  New World Health Organization (WHO) guidance will help countries accelerate efforts to stop people with tuberculosis (TB) infection becoming sick with TB by giving them preventive treatment. A quarter of the world‘s population
    is estimated to be infected with TB bacteria. These people are neither sick nor contagious. However, they are at greater risk of developing TB disease, especially those with weakened immunity. Offering them TB preventive treatment will not only protect
    them from becoming sick but also cut down on the risk of transmission in the community. Read more

    The full package is available below and at our World TB Day Campaign Page


    WHO Civil Society Taskforce on TB: Progress Review

    The WHO Civil Society Taskforce provides a platform for meaningful engagement of civil society, building on the commitment of the Director-General, with emphasis on harnessing the untapped potential in engagement with civil society and affected communities
    al all levels. To mark World TB Day 2020, the Task Force has released a Progress Review highlighting key achievements since its formation in 2018.

    Access link here


    WHO eTB guidelines: A digital platform to promote adolopment of TB recommendations

    World TB Day 2020 Newsletter 6

    WHO Global TB Programme / McMaster University

    The WHO Global Tuberculosis (TB) Programme, in collaboration with McMaster University, Canada, is developing a smart platform to improve access to and use of all WHO recommendations on TB prevention and care. The WHO eTB guidelines platform will facilitate
    the adoption, adaptation and implementation (“adolopment”) by countries of recommendations across the continuum of care. This digital platform will provide a variety of users – TB programme managers, healthcare workers including
    nurses, researchers, patients and affected communities – with easy access to all essential information about WHO-s current policy guidance on TB.

    The first set of recommendations on TB preventive treatment were released on this new platform on World TB Day.

    WHO eTB guidelines platform

    Infographic


    TB and COVID-19

    24 March 2020 News release

    Geneva –  As the world comes together to tackle the COVID-19 pandemic, it is important to ensure that essential health services and operations are continued to protect the lives of people with TB and other diseases or health conditions. Health services,
    including national programmes to combat TB, need to be actively engaged in ensuring an effective and rapid response to COVID-19 while ensuring that TB services are maintained. Read more


    Let’s never forget: It’s time to end TB

    Ksenia Schenina

    World TB Day 2020 Newsletter 7

    Ksenia Schenina

    24 March 2020 Photo story

    On World TB Day 2020, the theme – “Its time” – stresses the urgency to end the TB epidemic. TB survivor and advocate, Ksenia Schenina, talks about her struggle with the disease, the persistence of stigma and the role that remembrance can play
    in fighting it.   Through her TB memorial project, she aims to remember those who passed away from this terrible and ancient disease. “We do it to show what kind of people they were – what kind of things they liked, what kind of music
    they listened to and what their favorite movies were; if they liked fishing or dreamt of a flight to space,” she says. Read more


    Commentary

    To end TB, we must invest in research and innovation

    24 March 2020 Commentary

    If the world is to get anywhere near ending TB, a disease that killed more than 1.5 million people in 2018, something significant needs to change.

    TB remains the world’s leading infectious killer and yet, in the last 50 years, only three new drugs and regimes have been developed to combat the disease. “What we need is more research and more tools in the pipeline; better diagnostics,
    more effective vaccines, and safer, shorter drug regimes,” explains Dr Tereza Kasaeva, Director of the World Health Organization Global Tuberculosis Programme. Read more


    Emily: A Day in the Life of a TB Nurse

    World TB Day 2020 Newsletter 8

    Maria Emily C. Ballesteros

    Watch this story of Emily, a nurse managing the tuberculosis (TB) program of the City Health Office in Tuguegarao City. Her dream for Tuguegarao is to one day see zero TB cases and that no one dies from this infectious disease. Nurses and healthcare workers
    play a critical role in TB prevention and care. It’s time to invest in them to improve healthcare for all. We thank all the nurses, midwives and healthcare workers working to #EndTB! Watch the video


    Updates and messages

    New research tool supports scale-up of digital technologies to End TB

    24 March 2020 TDR news item

    National anti-tuberculosis efforts are increasingly involving digital technologies, such as mobile applications to support treatment adherence and electronic surveillance systems that enable real-time monitoring of a country’s TB situation. Read more

    World TB Day 2020: It’s Time for solidarity

    24 March 2020 HIV/TB news item

    At this unique time in history when the world is grappling with the COVID-19 pandemic, the WHO Department of Global HIV, Hepatitis and STI Programmes stands in solidarity with governments and communities as they seek to maintain health services
    and continue to address the needs of patients suffering from HIV and tuberculosis (TB).  Read more

    New, shorter treatment to prevent TB to be rolled out in five high TB burden countries

    24 March 2020 news item

    Three-month regimen expected to prevent TB in those at highest risk of developing the disease, including people living with HIV and children under the age of five
    Today, the Aurum Institute and its partners, as part of the IMPAACT4TB project, announced that five high-burden TB countries will roll out a new, shorter drug regimen (known as 3HP) to prevent TB. The announcement comes as countries around the world mark World TB Day, which takes place every year on March 24th. Countries that will initially provide the new regimen with funding from Unitaid, U.S. PEPFAR and the Global Fund include Cambodia, Ethiopia, Kenya, Malawi, South Africa and Zimbabwe. More than 120,000 patient courses of 3HP will be delivered by the project to 12 countries in 2020. An additional 1 million patient courses are expected to reach low- and middle-income countries by the end of the year, through the combined support of Unitaid, Global Fund, the Stop TB Partnership’s Global Drug Facility (GDF) and PEPFAR. Read more
    World TB Day 2020 Newsletter
    Read More
    https://www.who.int/news-room/detail/30-03-2020-world-tb-day-2020-newsletter

    Views: 0

  • Muhyiddin visits MAEPS low-risk patient Quarantine & Treatment Centre

    Muhyiddin visits MAEPS low-risk patient Quarantine & Treatment Centre

    Muhyiddin visits MAEPS low-risk patient Quarantine & Treatment Centre 9

    SERDANG: Prime Minister Tan Sri Muhyiddin Yassin today visited the Quarantine and Treatment Centre for low-risk Covid-19 patients at the Malaysia Agro Exposition Park Serdang (MAEPS) here.

    The prime minister was accompanied by Health Minister Datuk Seri Dr Adham Baba, Ministry of Health (MOH) secretary-general Datuk Seri Dr Chen Chaw Min and Health director-general Datuk Dr Noor Hisham Abdullah.

    Muhyiddin, who arrived at the centre at 5.45pm, spent almost an hour being briefed and touring the centre, which was successfully prepared for operations by various government agencies, under the coordination of the National Disaster Management Agency (Nadma), within three days.

    Met after the visit, Dr Adham told reporters that the centre was the brainchild of the prime minister himself to prepare for any possibility of a drastic surge in the number of Covid-19 infections.

    “We will treat Covid-19 positive patients who are asymptomatic or have mild symptoms here,” he said.

    The centre has the capacity to place up to 600 patients at any one time and it will be coordinated by Nadma with the cooperation of the MOH, the Armed Forces, the Fire and Rescue Department, the Civil Defence Force, the Social Welfare Department and the Public Works Department.

    Among others, it will provide clinical services, Covid-19 wards, resuscitation areas to stabilise patients during emergencies, as well as ambulance, pharmacy and pathology laboratory services.

    Facilities for patients include beds, tables and chairs, lockers, television, lounges, Wifi access, computers, surau, closed-circuit television (CCTV), toilets and baths, changing rooms and rest areas.

    For those on duty, there are nurse stations, treatment/resuscitation room, rest areas, changing rooms and baths, including for the ‘donning and doffing’ of personal protective equipment (PPE) as well as meeting and seminar rooms. – Bernama

    Muhyiddin visits MAEPS low-risk patient Quarantine & Treatment Centre
    Read More
    https://www.thesundaily.my/local/muhyiddin-visits-maeps-low-risk-patient-quarantine-treatment-centre-AN2197222

    Views: 0

  • 156 new Covid-19 cases as of noon today, tally now 2,626: Health DG (Updated)

    156 new Covid-19 cases as of noon today, tally now 2,626: Health DG (Updated)

    156 new Covid-19 cases as of noon today, tally now 2,626: Health DG (Updated) 10

    PETALING JAYA: There were 156 new Covid-19 cases, with three deaths recorded at noon today, which brings the total number of infected and deceased cases to 2,626 and 37, respectively.

    “To date, (out of the 2,626 new cases), 94 are being treated in intensive care and of these, 62 cases require breathing assistance,” Health director-general Datuk Dr Noor Hisham Abdullah said in a statement.

    He also noted that the country saw a record number of 91 patients having recovered and discharged in one day. This brings the number of those who have recovered to 479.

    There was no drastic increase of Covid-19 cases here so far.

    He explained that recording 150 to 200 cases a day is considered stable and attributes the number to active case inspections according to the ministry.

    “We have been observing cases closely and have compared the figures to other countries, to which we can say there has been no significant increase so far.”

    “What we fear is a sudden surge of between 900 to 1,000 cases in a day,“ he said.

    Hisham also shared that the Health Ministry has managed to increase the number of hospitals providing Covid-19 screening services across the nation, from 57 to 70 hospitals.

    The number of hospitals equipped to treat Covid-19 cases has also been increased from 26 to 38, thanks to cooperation from the Malaysian Armed Forces and the University of Malaya University Medical Center.

    “Seven of these hospitals are specialised in treating Covid-19 patients,” he said.

    Of the three fatalities, the 35th victim was a 57-year-old woman with a history of diabetes who had travelled to Indonesia. She was treated at the Sungai Buloh Hospital.

    Case 36 was a 47-year-old Malaysian, treated at the Sarawak General Hospital on March 23.

    Case 37 was A 46-year-old female. She had a history of high blood pressure and an autoimmune disease. She was hospitalised at the Miri Hospital in Sarawak.

    156 new Covid-19 cases as of noon today, tally now 2,626: Health DG (Updated)
    Read More
    https://www.thesundaily.my/local/156-new-covid-19-cases-as-of-noon-today-tally-now-2626-health-dg-updated-IM2196309

    Views: 0

  • ‘Chloroquine’ used to treat Covid-19 patients since first wave: Health DG

    ‘Chloroquine’ used to treat Covid-19 patients since first wave: Health DG

    ‘Chloroquine’ used to treat Covid-19 patients since first wave: Health DG 11

    PUTRAJAYA: Chloroquine, a drug used for malaria, has been used to treat Covid-19 patients since the first wave of the outbreak in Malaysia and has shown its efficacy, according to Health director-general Datuk Dr Noor Hisham Abdullah (pix).

    He said the anti-inflammatory properties of the drug were effective in treating Covid-19 which caused inflammation in the lower respiratory tract.

    “When the Covid-19 virus attaches to the lower respiratory tract it causes inflammation and replication of the virus and this drug helps treat the inflammation,” he told a press conference, here today.

    Besides ‘Chloroquine’, Dr Noor Hisham said the combination of ‘Lopinavir and Ritonavir’ and Hydroxychloroquine have also been used by Ministry of Health (MoH) since the first wave of the outbreak.

    He said the drugs used in the first wave of the infection showed promising results in treating Covid-19, however, further research was still required.

    He explained that the number of deaths due to the virus had increased as the patients were either elderly, had comorbidities such as high blood pressure and kidney disease, or those who sought treatment at a later stage or after they began having breathing difficulties.

    “We have tried the drug and it is also part of a joint study with the World Health Organization called ‘Solidarity Trial’ involving many other countries,“ he added.

    He said besides those medicines, studies would also focus on the latest drug, ‘Remdesivir’ as announced yesterday.

    “This is only for research, and drugs that we have used off-label such as Lopinavir and Ritonavir, those we have been using since the first wave,“ he added. – Bernama

    ‘Chloroquine’ used to treat Covid-19 patients since first wave: Health DG
    Read More
    https://www.thesundaily.my/local/chloroquine-used-to-treat-covid-19-patients-since-first-wave-health-dg-FJ2193799

    Views: 0

  • Coronavirus: United States Urges Doctors, Nurses Worldwide To Apply For Its Visas

    Coronavirus: United States Urges Doctors, Nurses Worldwide To Apply For Its Visas

    Coronavirus: United States Urges Doctors, Nurses Worldwide To Apply For Its Visas 12

    Coronavirus: United States Urges Doctors, Nurses Worldwide To Apply For Its Visas 13


    The United States Government has urged nurses and doctors around the world interested in working in America to put in for its work visas at the nearest US Embassy to them.

    The move is part of strategies the United States was adopting to increase the number of health workers combating the Coronavirus pandemic in the country.

    In a statement on Friday, the US authorities called on foreign medical professionals already in America to be in touch with their sponsors to extend their programmes.

    The statement read, “We encourage medical professionals seeking to work in the United States on a work or exchange visitor particularly those working to treat or mitigate the effects of COVID-19, to reach out to the nearest embassy or consulate to request a visa appointment.

    “For those foreign medical professionals already in the United States: J-1 Alien Physicians (medical residents) may consult with their programme sponsor, ECFMG, to extend their programmes in the United States. 

    “Generally, a J-1 program for a foreign medical resident can be extended one year at a time for up to seven years.”

    At least 63,570 people have been infected with the virus and nearly 884 have died in the United States.

    PUBLIC HEALTH

    United States of America

    News

    AddThis

    : 

    Original Author

    : 

    Saharareporters, New York

    Disable advertisements

    : 
    Coronavirus: United States Urges Doctors, Nurses Worldwide To Apply For Its Visas
    Read More
    http://saharareporters.com/2020/03/27/coronavirus-united-states-urges-doctors-nurses-worldwide-apply-its-visas

    Views: 0